Discounted Cash Flow (DCF) Analysis Levered
1Life Healthcare, Inc. (ONEM)
$16.47
0.00 (0.00%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 212.68 | 276.26 | 377.64 | 621.55 | 1,045.55 | 1,566.74 | 2,347.76 | 3,518.09 | 5,271.84 | 7,899.81 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -18.41 | -31.67 | -4.38 | -88.57 | -211.80 | -174.81 | -261.95 | -392.53 | -588.21 | -881.43 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -10.77 | -54.41 | -63.71 | -63.62 | -73.72 | -184.61 | -276.63 | -414.53 | -621.17 | -930.81 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -29.18 | -86.08 | -68.09 | -152.18 | -285.52 | -359.42 | -538.58 | -807.06 | -1,209.38 | -1,812.24 |
Weighted Average Cost Of Capital
| Share price | $ 16.47 |
|---|---|
| Beta | 0.000 |
| Diluted Shares Outstanding | 197.05 |
| Cost of Debt | |
| Tax Rate | 7.34 |
| After-tax Cost of Debt | 1.67% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 3.564 |
| Total Debt | 647.73 |
| Total Equity | 3,245.38 |
| Total Capital | 3,893.11 |
| Debt Weighting | 16.64 |
| Equity Weighting | 83.36 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 212.68 | 276.26 | 377.64 | 621.55 | 1,045.55 | 1,566.74 | 2,347.76 | 3,518.09 | 5,271.84 | 7,899.81 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.41 | -31.67 | -4.38 | -88.57 | -211.80 | -174.81 | -261.95 | -392.53 | -588.21 | -881.43 |
| Capital Expenditure | -10.77 | -54.41 | -63.71 | -63.62 | -73.72 | -184.61 | -276.63 | -414.53 | -621.17 | -930.81 |
| Free Cash Flow | -29.18 | -86.08 | -68.09 | -152.18 | -285.52 | -359.42 | -538.58 | -807.06 | -1,209.38 | -1,812.24 |
| WACC | ||||||||||
| PV LFCF | -348.10 | -505.21 | -733.22 | -1,064.14 | -1,544.42 | |||||
| SUM PV LFCF | -4,195.10 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 3.25 |
| Free cash flow (t + 1) | -1,848.48 |
| Terminal Value | -147,878.75 |
| Present Value of Terminal Value | -126,024.64 |
Intrinsic Value
| Enterprise Value | -130,219.74 |
|---|---|
| Net Debt | 96.27 |
| Equity Value | -130,316.01 |
| Shares Outstanding | 197.05 |
| Equity Value Per Share | -661.34 |